IN
Indo US Bio-Tech Ltd (INDOUS)
₹66.50
Mkt cap
₹133 Cr
P/E ratio
30.60
P/B
1.45
Div yield
0.00%
ROE
15.30%
ROCE
14.50%
EPS (TTM)
₹2.17
Book value
₹46
52W range
58–159
Sector
Fast Moving Consumer Goods
Price history
Previous close
Incorporated in 2004, Indo US Bio-Tech Ltd is engaged in production and processing of commercial and vegetable seeds [1]
NSE INDOUSBSE 541304
Health check
Cautious
ValuationExpensive
ProfitabilityAverage
GrowthModerate
TechnicalsBearish
52-week range
−58.18% from high₹67
₹58+15.65% from low₹159
Current
₹66.50
Prev close
₹66.46
Day
+0.06%
Price performance
1D
+0.06%
1W
+1.43%
1M
−2.11%
3M
−22.64%
6M
−34.59%
1Y
−49.03%
YTD
−45.42%
Financials
Revenue, profit & margin
P/E ratio
30.6×
INDOUS is 127% above the sector median of 13.5×
INDOUS30.6×
Sector median13.5×
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.81 | 22.11 | 15.77 | 24.72 | 22.17 | 23.56 | 33.38 | 30.77 | 30.85 | 22.80 | 26.02 | 32.99 | 15.05 | |
| YoY Sales growth | +14.98% | +42.65% | -12.92% | +29.15% | +40.23% | +6.56% | +111.67% | +24.47% | +39.15% | -3.23% | -22.05% | +7.21% | -51.22% | |
| Expenses | 13.21 | 17.88 | 14.79 | 21.03 | 17.05 | 18.02 | 28.80 | 25.30 | 26.69 | 18.65 | 22.79 | 29.02 | 17.66 | |
| Operating Profit | 2.60 | 4.23 | 0.98 | 3.69 | 5.12 | 5.54 | 4.58 | 5.47 | 4.16 | 4.15 | 3.23 | 3.97 | -2.61 | |
| OPM % | 16.45% | 19.13% | 6.21% | 14.93% | 23.09% | 23.51% | 13.72% | 17.78% | 13.48% | 18.20% | 12.41% | 12.03% | -17.34% | |
| Other Income | 0.00 | 0.08 | 0.21 | 0.03 | 0.02 | 0.02 | 0.12 | 0.00 | 0.03 | 0.01 | 0.02 | 0.12 | 0.05 | |
| Interest | 0.41 | 0.37 | 0.36 | 0.33 | 0.52 | 0.38 | 0.26 | 0.45 | 0.42 | 0.77 | 0.60 | 0.74 | 0.81 | |
| Depreciation | 0.21 | 0.19 | 0.20 | 0.20 | 0.18 | 0.16 | 0.56 | 0.20 | 0.21 | 0.22 | 0.27 | 0.27 | 0.28 | |
| Profit before tax | 1.98 | 3.75 | 0.63 | 3.19 | 4.44 | 5.02 | 3.88 | 4.82 | 3.56 | 3.17 | 2.38 | 3.08 | -3.65 | |
| Tax % | 15.66% | 1.87% | 17.46% | 0.63% | 2.03% | -0.80% | 4.90% | 2.49% | 3.09% | 5.36% | 17.23% | 1.30% | 0.55% | |
| Net Profit | 1.67 | 3.68 | 0.52 | 3.17 | 4.36 | 5.05 | 3.68 | 4.70 | 3.45 | 3.00 | 1.97 | 3.04 | -3.67 | |
| EPS in Rs | 0.83 | 1.84 | 0.26 | 1.58 | 2.17 | 2.52 | 1.84 | 2.34 | 1.72 | 1.50 | 0.98 | 1.52 | -1.83 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Sep 202668.29%Promoter
Promoters68.29%
FIIs0.01%
DIIs0.25%0.25
Public31.46%0.24
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| L T Foods | ₹424.45 | 22.45 | 14,739 | 0.71% | 180 | +9.98% | 3,234 | +16.94% | 17.60% |
| KRBL | ₹419.25 | 11.36 | 9,596 | 1.07% | 259 | +50.44% | 1,727 | +14.31% | 15.16% |
| Guj. Ambuja Exp | ₹146.99 | 13.15 | 6,742 | 0.20% | 132 | +246.63% | 1,451 | −2.42% | 12.46% |
| Kaveri Seed Co. | ₹716.05 | 14.37 | 3,683 | 0.70% | −9 | +43.10% | 244 | +11.53% | 15.82% |
| TruAlt Bioenergy | ₹339.50 | 12.71 | 2,911 | 0.00% | 35 | +191.41% | 811 | +606.16% | 10.44% |
| A C J K Exports | ₹237.90 | 18.61 | 2,463 | 0.00% | 41 | +26.17% | 694 | +16.96% | 15.66% |
| Sanstar | ₹99.52 | 40.48 | 1,993 | 0.00% | 6 | +831.75% | 218 | +11.12% | 5.83% |
| Indo US Bio-Tech | ₹66.20 | 30.59 | 133 | 0.00% | −4 | −206.38% | 15 | −51.22% | 14.50% |
| Median: 39 Co. | ₹136.19 | 13.47 | 461 | 0.00% | 7 | +42.34% | 217 | +20.95% | 14.38% |
Filings
Annual reports10
Announcements5
Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Oct - Newspaper Publication Unaudited Financial Results for the quarter ended on 30-09-2026.Results- Financial Results For September 30, 2026 30 OctBoard Meeting Outcome for Outcome Of Board Meeting Held On Friday, October 30, 2026, Pursuant To Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015. 30 Oct - Board approved unaudited results for quarter/half-year ended 30 September 2026.Board Meeting Intimation for Considering, Approving And Take On Record The Un-Audited Standalone Financial Result Of The Company For The Quarter And Half Year Ended 30Th September, 2026. 24 Oct - Board meeting on 30 Oct 2026 to consider Q2 and half-year unaudited standalone financial results.Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 Regarding Directors Cum Promoters And Other Promoter Visit To China. 23 Oct - Promoters invited to attend the 140th Canton Fair in Guangzhou, China.



